🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Enlightening discussions with Dr. Johanna Bendell - Vivek Subbiah, MD Pfizer Inc. oncodaily.com/url/292603 #OncoDaily #Oncology #Cancer #Health #Medicine #MedX

1/5 People living with sickle-cell disease (SCD) face ↑ cancer risk, including #RenalMedullaryCarcinoma. Our latest Immunity study suggests a culprit is the reshaping CD8⁺ T cell chromatin by SCD 👉authors.elsevier.com/sd/article/S10… #MsaouelLab

“We owe the progress to patients.” Gabriel N. Hortobagyi receives the 2025 #ESMO Breast Cancer Award. A tribute to the courage of patients who shaped the future of care—by saying yes to trials, hope, and humanity. #ESMODaily #BreastCancer #Oncology #ClinicalTrials #ESMO25

🚨‼️FDA Grants Accelerated Approval to Telisotuzumab Vedotin In Pretreated Advanced NSCLC With c-MET Overexpression #PrecisionMedicine OncoAlert onclive.com/view/fda-grant… via @onclive

🚨FDA Approves Belzutifan for Advanced Pheochromocytoma and Paraganglioma onclive.com/view/fda-appro… via @onclive

Join me, Tian Zhang, MD, MHS & Dr. David McDermott for a PeerView x @KCCure symposium on personalized RCC care at #ASCO25, May 31 @ 7PM CDT! We’ll cover frontline IO combos, sequencing & AEs. Join us in Chicago or online - register here: shorturl.at/yk8Dg

The Abstracts for the European Hematology Association 2025 Congress are here. Get the latest #EHA2025 updates: t.ly/6uoHY #LARVOL #CancerResearch #Hematology #Oncology #CancerData #CancerData #OncologyInsights #ClinicalTrials | LARVOL | Matteo Lambertini, MD PhD | Mark Lewis, MD, FASCO | Vivek Subbiah, MD

Our #TranslationalMedicine Link of the Week, chosen by SWOG Cancer Research Network's Lee Ellis & Jimmy Rae, PhD: Designing Clinical Trials for Patients with Rare Cancers: Connecting the Zebras Razelle Kurzrock, MD Vivek Subbiah, MD doi.org/10.1200/EDBK-2…

Inspiring Journey of the 2024 Yvonne Awardees — A Year of Impact and Leadership Vinod BalachandranMD | Pashtoon Kasi MD, MS | Dr. Asya Agulnik | Omojokun Foluke Sarimiye | Abeid Athman (Omar). | Maria (Masha) Babak, PhD |Vivek Subbiah, MD oncodaily.com/blog/yvonne-29… #Oncology #CancerResearch #Cancer #MedEd #MedX #CancerAdvocacy

🤩Thrilled for another fantastic #IMGoncCoP meeting ASCO #ASCO25! 🙏With an outstanding lineup of presenters, we'll review the excellent work of our subcommittees, and hear the inspiring #IMG stories and explore ways to better ways to support IMGs. 💫Join us for an engaging

🎥 In case you missed it: Dr. Vivek Subbiah, MD shares powerful reflections on expanding trial access for rare cancers and engaging patients from the start. 👉 Watch the interview: lnkd.in/eXF7Wima #WorldClinicalTrialsDay #RareCancers #PatientEngagement #ICPC2025

🚨🥁Exciting Nature Medicine Publication Announcement 👉Hot off the press on this #ClinicalTrialsDay ! Thrilled to share our Nature Medicine paper: "Cancer treatment paradigms in the precision medicine era" 👉We propose 5 BOLD strategic recommendations to modernize cancer

Time to rethink cancer trials. 🧬 Precision oncology demands: -Early molecular profiling -Flexible evidence (Phase 1/2, real-world) -Tumor-agnostic approvals - Global equity New era, new rules. Nature Cancer OncoAlert Vivek Subbiah, MD G Curigliano MD PhD Razelle Kurzrock, MD ASCO ESMO - Eur. Oncology ECOG-ACRIN Cancer Research Group

"Ultimately, we need to implement #universal #somatic and #germlinetesting in all #patients with #cancer if we are serious about beating most cancer types. " Vivek Subbiah, MD et al. Nature Medicine c/w ascopubs.org/doi/10.1200/PO… JCO Precision Oncology ASCO Invitae Labcorp

Cancer Treatment Paradigms in The Precision Medicine Era - Vivek Subbiah (Vivek Subbiah, MD) oncodaily.com/science/vivek-… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #PrecisionMedicine #CancerTreatment CancerWorld

🔥 Nature Medicine 🆙 ✅Cancer treatment paradigms in the precision medicine era 🎯Re-evaluate RCT requirements 🎯Early molecular profiling and matched Tx 🎯Pan-cancer, tumor-agnostic targets 🎯Supportive regulatory frameworks 🎙️ Vivek Subbiah, MD OncoAlert nature.com/articles/s4159…

Designing Clinical Trials for Patients With Rare Cancers - Vivek Subbiah, MD Razelle Kurzrock, MD ASCO oncodaily.com/url/298307 #Cancer #OncoDaily #Oncology #GlobalAwareness #FightAgainstCancer #CancerWorld #RareCancers #ASCO25

⭐️Delighted to welcome my dear friend & colleague, Dr. Hans Lee as our Myeloma leader ⁦Sarah Cannon Docs⁩ joining as Director of Myeloma Research & ⁦SCRI Oncology Partners⁩ ! ⭐️So excited for the impact he'll make in advancing research & patient care. scri.com/news/sarah-can…

🚨ASCO & Google create ‘walled garden’ AI tool for doctors to query #ASCO guidelines #ASCO25 OncoAlert statnews.com/2025/05/21/asc… via STAT Matthew Herper Clifford Hudis #AI

Breaking News 👉ASCO #ASCO25 Abstracts are out! For full-length abstracts, here is the weblink👉bit.ly/4krWlYh OncoAlert UroToday.com Uromigos Oncology Brothers